XML 13 R2.htm IDEA: XBRL DOCUMENT v3.20.2
Consolidated Statements of Income - USD ($)
shares in Thousands
3 Months Ended 9 Months Ended
Sep. 25, 2020
Sep. 27, 2019
Sep. 25, 2020
Sep. 27, 2019
Income Statement [Abstract]        
Net sales $ 287,171,000 $ 305,979,000 $ 836,585,000 $ 905,263,000
Cost of sales 240,531,000 240,748,000 696,280,000 701,126,000
Gross margin 46,640,000 65,231,000 140,305,000 204,137,000
Selling, general, and administrative expense 35,696,000 35,812,000 99,292,000 115,767,000
Research and development expense 5,417,000 5,262,000 14,104,000 13,064,000
Goodwill impairment charges 0 11,560,000 9,053,000 11,560,000
Asset impairment charges 0 2,581,000 1,713,000 2,581,000
Restructuring expense 2,593,000 785,000 7,144,000 785,000
Other - net 2,221,000 2,942,000 4,143,000 9,954,000
Operating profit 713,000 6,289,000 4,856,000 50,426,000
Other non-operating (income) expense - net (1,076,000) 127,000 (2,871,000) 3,484,000
Interest Expense-net 1,334,000 436,000 2,839,000 1,402,000
Income before income taxes 455,000 5,726,000 4,888,000 45,540,000
Income tax (benefit) expense (6,041,000) 2,263,000 (5,183,000) 9,631,000
Net income $ 6,496,000 $ 3,463,000 $ 10,071,000 $ 35,909,000
Basic earnings per share:        
Net income per share of common stock (in dollars per share) $ 0.32 $ 0.17 $ 0.50 $ 1.76
Diluted earnings per share:        
Net income per share of common stock (in dollars per share) $ 0.32 $ 0.17 $ 0.49 $ 1.74
Weighted-average number of shares of common stock outstanding:        
Basic (in shares) 20,325 20,401 20,342 20,351
Diluted (in shares) 20,592 20,677 20,595 20,645